Alzheimer’s disease (AD) is an idiopathic, primary, degenerative form of neurological disorder that accounts from 60 to 80 percent of worldwide dementia cases. This pathology usually manifests as slight loss of memory and other neurocognitive skills, becoming gradually more acute. Anamnestic mild cognitive impairment (aMCI) refers to a condition of degeneration of cognitive functions: studies reported that in 65% of cases, it represents a transitional state from normal ageing to Alzheimer’s disease. Its symptoms are not yet clearly identified, and the degree of deterioration is difficult to determine. Nowadays dementia diagnosis requires time consuming and qualitative screening tests and mostly expensive medical images exams like brain magnetic resonance.